SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer. Shen X, Wang G, He H, Shang P, et al. Breast Cancer 2023 Nov 2. doi: 10.1007/s12282-023-01516.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shen X, Wang G, He H, Shang P, et al. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer. Breast Cancer 2023 Nov 2. doi: 10.1007/s12282-023-01516.
PMID: 37914960